Ameritas Investment Partners, Inc. Alaunos Therapeutics, Inc. Transaction History

Ameritas Investment Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.41 - $1.24 $7,721 - $23,351	-18,832 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$2.2 - $3.71 $11,242 - $18,958	5,110 Added 37.24%	18,832 $62,000
Q2 2019 Aug 14, 2019	BUY	$3.98 - $6.2 $10,968 - $17,087	2,756 Added 25.13%	13,722 $80,000
Q2 2018 Aug 13, 2018	BUY	$3.02 - $4.94 $1,422 - $2,326	471 Added 4.49%	10,966 $33,000
Q2 2017 Aug 15, 2017	BUY	N/A	10,495	10,495 $65,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.